🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Malignant Digestive System Neoplasm

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers NCT02584244Phase 1, Phase 21 site📍 Boston Lumicell, Inc. · Tests: LUM015, LUM 2.6 Imaging Device Development of Clinical and Biological Database NCT03449264NA1 site📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: biological collection A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies NCT04678648Phase 13 sites📍 Los Angeles📍 Denver📍 Nashville RasCal Therapeutics, Inc. · Tests: RSC-1255 Dose Escalation, RSC-1255 Dose Expansion The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors NCT07159048NA1 site📍 Shanghai Fudan University · Tests: Multimodal Tumor Thermal Therapy System, Radiofrequency Ablation System or Microwave Ablation System An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site📍 Padova Azienda Ospedaliera di Padova MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy Outcomes NCT04534543NA2 sites📍 Amsterdam📍 Utrecht Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: MRI/Spectroscopy Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining NCT00242723n/a1 site📍 Bethesda National Cancer Institute (NCI) Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites📍 Denver📍 Atlanta📍 Fairway Verismo Therapeutics · Tests: SynKIR-310 CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC NCT06643793Phase 21 site📍 Nanjing Affiliated Hospital of Nantong University · Tests: Irinotecan liposome (ll) + 5-FU/LV + bevacizumab Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) NCT06277531n/a2 sites📍 Beijing📍 Beijing Peking University Third Hospital An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response NCT04796818NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Diffusion Weighted Imaging BGT007 Cells for the Treatment of Refractory Digestive System Tumors NCT06104241EARLY Phase 11 site📍 Xuzhou The Affiliated Hospital of Xuzhou Medical University · Tests: BGT007 Injection Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention NCT07649681NA6 sites📍 Augsburg📍 Erlangen📍 München Wuerzburg University Hospital · Tests: Gustabor server, Standard Recommendations A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) NCT05865002Phase 137 sites📍 Vijayawada📍 Visakhapatnam📍 Chandigarh Aurigene Discovery Technologies Limited · Tests: AUR107 EUS Guided HVA and PVA for Circulating Tumor DNA in Patients NCT04782557NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: EUS-guided portal vein and hepatic vein aspiration Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Immune Checkpoint Inhibitor TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors NCT06487663NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: TACE with ICI CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Avapritinib A First in Human Study of PLT012 in Participants With Solid Tumor Cancers NCT07337525Phase 14 sites📍 Los Angeles📍 Dallas📍 Houston Pilatus Biosciences Inc · Tests: PLT012 Feasibility Study of CBCT for IGRT in Cancer Patients NCT06681233NA4 sites📍 Columbus📍 Columbus📍 Columbus Varian, a Siemens Healthineers Company · Tests: Comparison of HyperSight CBCT imaging to conventional CBCT imaging. Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme NCT06475352Phase 241 sites📍 Amiens📍 Aurillac📍 Avignon UNICANCER · Tests: FOLFOX regimen, CAPOX regimen FL-261 Imaging for Cancer Diagnosis and Staging NCT07510321n/a1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: [68Ga]Ga-FL-261 PET Imaging / [111In]In-FL-261 SPECT Imaging Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies NCT06626269NA2 sites📍 Besançon📍 Dijon Centre Hospitalier Universitaire de Besancon · Tests: Blood sample, Tumor tissue Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease NCT03972956n/a1 site📍 Wuhan Renmin Hospital of Wuhan University · Tests: No intervention will be given to patients. TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma NCT07189195Phase 11 site📍 Sacramento University of California, Davis · Tests: TR-002 Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors NCT05969041Phase 16 sites📍 Darlinghurst📍 Randwick📍 Westmead Myeloid Therapeutics · Tests: MT-302 (A)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy